Loading organizations...
§ Private Profile · London, London SE1 3JT, GB
Digital therapeutics company offering sustainable weight loss and type 2 diabetes reversal programs via mobile app.
Habitual is a London, UK-based digital health company focused on sustainable weight loss and type 2 diabetes reversal through nutritional treatment and behavioral change support, delivered entirely via a mobile app. The company has raised approximately £4.01 million in total funding, including a recent £1 million investment from Lexham Partners in April 2025. Operating as a digital therapeutics and healthcare services provider, Habitual serves both NHS and private patients with its low-calorie meal replacement plans and daily bite-sized, app-delivered digital content, designed by behavioral scientists. Key investors include Seedcamp, MMC Ventures, and Lexham Partners, supporting its expansion in the weight management market. Founded in September 2019 by Napala Pratini and Dr Ian Braithwaite, Habitual initially launched publicly in 2021 with a focus on type 2 diabetes remission, later expanding to general weight loss.
Habitual has raised $4.1M across 3 funding rounds.
Key people at Habitual.
Habitual has raised $4.1M in total across 3 funding rounds.
Habitual has raised $4.1M across 3 funding rounds. Most recently, it raised $1.4M Other Equity in April 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 14, 2025 | $1.4M Venture Round | — | — | Announced |
| Oct 5, 2021 | $2.3M Seed | — | — | Announced |
| Nov 1, 2020 | $430K Seed | — | Balderton Capital, Maki.vc, MMC Ventures, Northzone, Rogue VC, Seedcamp, VTF Capital, Dave Peacock, Nicolas Brusson, Steve Barham, TIM Sadler, Vernon Davis | Announced |
Key people at Habitual.
Habitual is a London-based digital health startup founded in 2019 that provides a comprehensive weight management program for individuals with type 2 diabetes, prediabetes, or obesity.[1][2] It combines nutritionally controlled meal replacements, medication-based options, and a behavior change app offering digital coaching, peer support, habit-tracking tools, and personalized lessons rooted in behavioral science, neuroscience, and psychology to drive sustainable weight loss and diabetes remission.[1][2][3][4] The direct-to-consumer service targets self-referring users via weekly or monthly subscriptions, addressing the global obesity crisis and overburdened healthcare systems by enabling medication-free living through long-term habit formation.[1][2] Habitual has raised over £4M ($3M+ USD) across three rounds, achieved profitability in 2025, and plans to expand user growth, team size, and clinical trials.[1][2]
Habitual was founded in September 2019 by co-founders including Napala Pratini (COO), driven by clinical research on nutrition's role in reversing type 2 diabetes and the need for scalable weight management solutions amid rising chronic disease rates.[1][2] The idea emerged from evidence showing nutritionally complete, low-calorie diets combined with habit change could yield sustainable results, prompting a shift from research to a consumer product.[2] It launched publicly in 2021 with diabetes remission programs featuring meal replacements and daily content, later expanding to general weight loss after users without diabetes sought services.[2] Early traction included pre-seed and seed funding, with a pivotal $2.3M (£1.7M) seed round in 2023 led by Atlantic Food Labs, joined by Seedcamp, MMC, and Oxford Seed Fund, bringing total funding to over $3M initially.[1] By 2025, it secured additional capital including an Innovate UK grant, reaching profitability.[2]
Habitual rides the digital health wave targeting chronic diseases like type 2 diabetes and obesity, projected to cost over $1 trillion annually by 2025, accelerated by COVID-19's boost to virtual care and patient demand for lifestyle interventions.[1] Its timing aligns with surging adoption of behavior change apps and personalized nutrition tech, countering healthcare system strains from rising chronic conditions.[1][2] Market forces favoring it include global obesity epidemics, regulatory support for digital therapeutics (e.g., Innovate UK grants), and investor interest in scalable DTC health solutions.[2] Habitual influences the ecosystem by pioneering holistic diabetes remission models, inspiring similar ventures in preventive care and proving profitability in digital health amid economic pressures.[1][2]
Habitual's profitability in 2025 positions it for aggressive scaling, with future funding fueling user acquisition, team expansion, and rigorous clinical trials to validate outcomes and attract partnerships with healthcare providers.[1][2] Trends like AI-enhanced personalization, GLP-1 medication integration, and global telehealth growth will amplify its momentum, potentially expanding beyond diabetes/obesity to broader wellness.[2][4] Its influence may evolve from DTC innovator to ecosystem leader, licensing programs or powering NHS-style integrations, ultimately helping millions reverse chronic conditions in a post-pandemic health paradigm—transforming "Habitual" from a startup name to a verb for sustainable health change.[1][2][3]
Habitual has raised $4.1M in total across 3 funding rounds.
Habitual's investors include Balderton Capital, Maki.vc, MMC Ventures, Northzone, Rogue VC, Seedcamp, VTF Capital, Dave Peacock, Nicolas Brusson, Steve Barham, Tim Sadler, Vernon Davis.
